STAT

Supreme Court agrees to review ‘skinny labeling’ and generic drug access

The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely ...
The American SpectatorOpinion

Why Is RFK Jr.’s FDA Allowing Abortionists to Flood Red States With Pills?

It has long been ignored that the Biden administration de facto guaranteed legal abortion in all 50 states just 15 days after ...

Republican lawmakers call for FDA to review abortion pill restrictions at Senate hearing

The Senate’s health committee convened its first hearing of the year on the efficacy of the chemical abortion drug ...

Study finds FDA used evidence, not politics, in abortion pill decisions

The abortion pill mifepristone has long been at the center of heated political discussions. But a new review suggests that ...

Factbox-US abortion pill access under fire: Lawsuits and regulatory battles to watch in 2026

Jan 5 (Reuters) - Since the U.S. Supreme Court rolled back the constitutional right to abortion in 2022, nearly half of U.S.